What is Fresenius Medical Care AG & Co. KGaA - ADR Quarterly Net Profit?

Fresenius Medical Care AG & Co. KGaA - ADR Quarterly Net Profit Fresenius Medical Care AG & Co. KGaA (ADR) Jun-2026 Quarterly Net Profit is $218 Million which is growth of -3.1% YoY.

What is Fresenius Medical Care AG & Co. KGaA - ADR Annual Revenue?

Fresenius Medical Care AG & Co. KGaA - ADR Annual Revenue Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Annual Revenue is $19,628 Million which is growth of 1.5% YoY.

What is Fresenius Medical Care AG & Co. KGaA - ADR Annual Net Profit?

Fresenius Medical Care AG & Co. KGaA - ADR Annual Net Profit Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Annual Net Profit is $978 Million which is growth of 81.9% YoY.

What is Fresenius Medical Care AG & Co. KGaA - ADR Total Shareholders Fund?

Fresenius Medical Care AG & Co. KGaA - ADR Total Shareholders Fund Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Total Shareholders Fund is $13,310 Million which is growth of -8.7% YoY.

What is Fresenius Medical Care AG & Co. KGaA - ADR Total Assets?

Fresenius Medical Care AG & Co. KGaA - ADR Total Assets Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Total Assets is $31,002 Million which is growth of -7.6% YoY.

What is Fresenius Medical Care AG & Co. KGaA - ADR Book Value Per Share?

Fresenius Medical Care AG & Co. KGaA - ADR Book Value Per Share Fresenius Medical Care AG & Co. KGaA (ADR) Book Value Per Share is $27 which is growth of 3.5% YoY.

What is Fresenius Medical Care AG & Co. KGaA - ADR ROE?

Fresenius Medical Care AG & Co. KGaA - ADR ROE Fresenius Medical Care AG & Co. KGaA (ADR) ROE is 0% which is growth of 0% YoY.

What is Fresenius Medical Care AG & Co. KGaA - ADR Cash From Operating Activity?

Fresenius Medical Care AG & Co. KGaA - ADR Cash From Operating Activity Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Cash From Operating Activity is $2,681 Million which is growth of 12.4% YoY.

What is Fresenius Medical Care AG & Co. KGaA - ADR Net Cash Flow?

Fresenius Medical Care AG & Co. KGaA - ADR Net Cash Flow Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Net Cash Flow is $555 Million which is growth of 307.1% YoY.

Fresenius Medical Care AG & Co. KGaA - ADR

XNYS: FMS

Mid-range Performer

Download real time

0.18(0.86%)

1.0M

XNYS Volume

XNYS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Fresenius Medical Care AG & Co. KGaA (ADR) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Q: What is Fresenius Medical Care AG & Co. KGaA - ADR Quarterly Revenue?

Fresenius Medical Care AG & Co. KGaA - ADR Quarterly Revenue Fresenius Medical Care AG & Co. KGaA (ADR) Jun-2026 Quarterly Revenue is $4,861 Million which is growth of 1.4% YoY.

View Charts

Forecaster Analyst Estimates for Fresenius Medical Care AG & Co. KGaA (ADR) share price target, revenues, EPS, net income and more

Fresenius Medical Care AG & Co. KGaA (ADR) quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Fresenius Medical Care AG & Co. KGaA (ADR) Jun-2026 Quarterly Revenue is $4,861 Million which is growth of 1.4% YoY.
NEGATIVE
Quarterly Net Profit Fresenius Medical Care AG & Co. KGaA (ADR) Jun-2026 Quarterly Net Profit is $218 Million which is growth of -3.1% YoY.

Fresenius Medical Care AG & Co. KGaA - ADR, Earnings Report - Quarterly Results, standalone, All financials are in EUR Million and price data in USD
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
SR_Q Operating Rev.	4,860.6	4,612.2	5,069.6	4,884.9	4,791.7	4,881.5	5,084.8	4,760.2	4,766	4,724.5	4,987.9	4,936.2	4,825.3
CostOfRevenue_Q Cost Of Rev.	3,550.6	3,432.7	3,681.2	3,642.6	3,577.4	3,697.5	3,814.4	3,614.1	3,600	3,550.9	3,638.2	3,707.2	3,628.1
GrossProfit_Q Gross Profit	1,310	1,179.5	1,388.4	1,242.2	1,214.4	1,184	1,270.4	1,146.1	1,166	1,173.7	1,349.7	1,229	1,197.2
OEXPNS_Q Operating Exp. ⌄	772.7	803.9	839.4	740.5	820	802.3	871.5	812.6	774	812.2	716.4	927.4	840.2
AdminAndSellingExpenses_Q Admin Plus Selling Exp.	736	748.9	784.6	705.4	792	750.7	839.6	756.2	771	775.6	845.2	793.8	775.2
ResearchAndDevlopmentExpenses_Q RnD Exp.	39.6	38.3	38.6	37.8	38.1	43.5	50.1	40.1	46	47.8	66	53	57.2
OP_Q Operating Profit	537.3	375.6	549	501.7	394.4	381.7	398.9	333.5	392	361.5	633.3	301.6	357
NetNonOperIntIncExp_Q Net Non Operations Interest Incuding Expenses ⌄	-82.9	-78.7	-85.4	-73.9	-74.7	-80.7	-79.8	-82.2	-85	-88.2	-84.6	-88.7	-80.5
Others_Q Other Interest Earned	14.7	14.6	13.6	19.2	21.9	15	21.2	16.9	18	15.7	26.9	25.1	24.1
IntExpNonOperating_Q Interest Exp. Non Operating	97.6	93.3	99	93.1	96.6	95.7	101	99.1	103	103.9	111.5	113.9	104.7
PBT_Q Profit Before Tax	383	207.5	508.5	402.6	350.6	250.7	179.1	380.5	340	157.8	343.1	235.5	276.1
TAX_Q Tax	89.8	42.8	106.4	75.2	78.3	61	61	116.5	99	39.5	86.5	88.5	81.1
NICommonStockholders_Q Net Income Common Stockholders ⌄	218.4	117.5	327.1	274.8	225.3	151.2	66.9	213	187	71	187.9	84.4	140.4
NP_Q Net Profit	218.4	117.5	327.1	274.8	225.3	151.2	66.9	213	187	71	187.9	84.4	140.4
NIIncludingNoncontrollingInterests_Q Net Income Including Non controlling Interests	293.2	164.8	402	327.3	272.3	189.6	118.1	264	241	118.3	256.6	147.1	195
DilutedNIAvailtoComStockholders_Q Diluted NI Avail to Com Stockholders Ann.	218.4	117.5	327.1	274.8	225.3	151.2	66.9	213	187	71	187.9	84.4	140.4
EPS_Q Basic EPS	0.4	0.2	0.6	0.5	0.4	0.3	0.1	0.4	0.3	0.1	0.3	0.1	0.2
AfterDilutedEPS_Q Diluted EPS After ExtraOrdinary	0.5	0.4	0.6	0.6	0.4	0.4	0.3	0.3	0.3	0.3	0.3	0.1	0.3
SHARE_Q Number Of Shares End	536.9	550.5	571.7	584.2	586.8	586.8	586.8	586.8	586.8	586.8	586.8	586.8	586.8
NIContinuingDiscontinuedOper_Q Net Income Continuing Discontinued Operations	218.4	117.5	327.1	274.8	225.3	151.2	66.9	213	187	71	187.9	84.4	140.4
NormalizedIncome_Q Normalized Income	310.5	251	412	413.8	269.2	306.8	266	194	241	212.3	429	147.1	175
InterestIncome_Q Interest Income	14.7	14.6	13.6	19.2	21.9	15	21.2	16.9	18	15.7	26.9	25.1	24.1
INT_Q Interest	97.6	93.3	99	93.1	96.6	95.7	101	99.1	103	103.9	111.5	113.9	104.7
NetInterestIncome_Q Net Interest Income	-82.9	-78.7	-85.4	-73.9	-74.7	-80.7	-79.8	-82.2	-85	-88.2	-84.6	-88.7	-80.5
EBIT_Q EBIT	465.9	286.2	593.9	476.5	425.3	331.4	258.9	462.7	425	246	427.7	324.2	356.6
EBITDA_Q EBITDA	829	749.1	967.4	833.8	801.3	725.8	735.9	462.7	812	758.5	853.6	324.2	790.6
ReconciledCostOfRevenue_Q Reconciled Cost Of Rev.	3,550.6	3,432.7	3,681.2	3,642.6	3,577.4	3,697.5	3,814.4	3,614.1	3,600	3,550.9	3,638.2	3,707.2	3,628.1
ReconciledDepreciation_Q Reconciled Depr.	363.1	462.9	373.6	357.3	375.2	394.4	477	366.3	387	512.4	425.9	454	434
ProfitLossFromContinuingOperations_Q Profit From Continuing Operations	293.2	164.8	402	327.3	272.3	189.6	118.1	264.8	241	118.3	256.6	147	195
NormalizedEBITDA_Q Normalized EBITDA	873.8	894.4	977.8	924.8	836.7	838.9	929.3	758	830	918.4	880.5	349.4	863.4

*All financials are in EUR Million and price data in USD

Add metric to table

Search...

Fresenius Medical Care AG & Co. KGaA (ADR) competitor comparison and performance snapshot within industry

Fresenius Medical Care AG & Co. KGaA (ADR) annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Annual Revenue is $19,628 Million which is growth of 1.5% YoY.
POSITIVE
Annual Net Profit Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Annual Net Profit is $978 Million which is growth of 81.9% YoY.

Fresenius Medical Care AG & Co. KGaA - ADR, Earnings Report - Annual Results, standalone, All financials are in EUR Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
SR_A Total Rev. Ann. ⌄	0.4%	1.9%		19,627.6	19,335.9	19,453.6	19,398	17,618.7	17,859.1	17,476.6	16,546.9	17,783.6	17,030.3	15,309.2
TotalOperatingRevenues_A Operating Rev. Ann.	0.4%	1.9%	19,427.1	19,627.6	19,335.9	19,453.6	19,398	17,618.7	17,859.1	17,476.6	16,546.9	17,783.6	17,439.4	15,683.8
CostOfRevenue_A Cost Of Rev. Ann.	1.2%	3.4%	14,307.1	14,598.7	14,579.3	14,528.6	14,087.8	12,541.7	12,321.6	12,080.7	11,392.1	11,779.9	11,534.8	10,433
GrossProfit_A Gross Profit Ann.	-1.8%	-1.9%	5,120.1	5,028.9	4,756.7	4,925	5,310.3	5,077	5,537.4	5,395.9	5,154.7	6,003.7	5,495.5	4,876.2
OEXPNS_A Operating Exp. Ann.	-7.3%	-0.9%	3,156.5	3,202.1	3,289.3	3,448.4	4,013.3	3,316.9	3,358.3	3,228.8	2,999.3	3,708.5	3,049.4	2,776.8
OP_A Operating Profit Ann.	12.1%	-3.5%	1,963.5	1,826.8	1,467.4	1,476.6	1,297	1,760.1	2,179.1	2,167.1	2,155.5	2,295.2	2,446.2	2,099.4
NetNonOperIntIncExp_A Net Non Operations Interest Incuding Expenses Ann, ⌄	-	-	-320.9	-314.8	-335.5	-336.4	-292.5	-280.4	-368	-429.4	-301.1	-353.9	-385.6	-358.1
Others_A Other Interest Earned Ann.	0.9%	10.6%	62.1	69.6	71.6	88.2	67.7	73.2	42	61.6	147.4	43.3	44.4	106.6
IntExpNonOperating_A Interest Exp. Non Operating Ann.	2.2%	-1.3%	383	384.4	407	424.6	360.1	353.6	410	491.1	448.5	397.2	430	464.7
OtherExpenses_A Other Exp. Ann.	-90.2%	-72.4%		0.2	-75	-107.2	214.8	92.2	125.3	102.5	882.4	67.2	61.7	28.8
PBT_A PBT Ann.	7.4%	-4.8%	1,501.5	1,512.2	1,056.9	1,033	1,219.3	1,571.9	1,936.4	1,840.1	2,736.7	2,008.6	2,122.3	1,770.1
TAX_A Tax Ann.	-0.4%	-8.5%	314.3	321	316.1	300.6	325	352.8	500.6	401.6	511.1	454	649.6	569
NICommonStockholders_A Net Income Common Stockholders Ann. ⌄	13.3%	-3.4%	937.8	978.4	537.9	499	673.4	969.3	1,164.4	1,199.6	1,981.9	1,279.8	1,182.2	941.6
NP_A Net Profit Ann.	13.3%	-3.4%	937.8	978.4	537.9	499	673.4	969.3	1,164.4	1,199.6	1,981.9	1,279.8	1,182.2	941.6
NIIncludingNoncontrollingInterests_A Net Income Including Non controlling Interests Ann.	10%	-3.7%	1,187.3	1,191.3	740.9	732.5	894.3	1,219	1,435.8	1,438.5	2,225.7	1,554.5	1,472.7	1,201.1
DilutedNIAvailtoComStockholders_A Diluted NI Avail to Com Stockholders Ann.	13.3%	-3.4%	937.8	978.4	537.9	499	673.4	969.3	1,164.4	1,199.6	1,981.9	1,279.8	1,182.2	941.6
EPS_A EPS Ann.	12.3%	-3.2%		1.7	0.9	0.9	1.2	1.7	2	2	3.2	2.1	1.8	1.5
DilutedEPS_A Diluted EPS Ann.	12.3%	-3.2%		1.7	0.9	0.9	1.2	1.7	2	2	3.2	2.1	1.8	1.5
SHARE_Q Number Of Shares End	-0.9%	-0.5%		571.7	586.8	586.8	586.8	586	585.7	598.5	613.7	613.8	612.4	610.3
TotalExpenses_A Total Exp. Ann.	-0.6%	2.6%		17,800.8	17,868.5	17,977	18,101	15,858.6	15,680	15,309.5	14,391.4	15,488.3	14,584.2	13,209.8
NIContinuingDiscontinuedOper_A Net Income Continuing Discontinued Operations Ann.	13.3%	-3.4%	937.8	978.4	537.9	499	673.4	969.3	1,164.4	1,199.6	1,981.9	1,279.8	1,182.2	941.6
NormalizedIncome_A Normalized Income Ann.	19.4%	0.4%	1,387.3	1,397.4	871.8	863.9	821.6	1,253.2	1,369.8	1.4	1.2	1,500.5	1,417.7	1,189.8
InterestIncome_A Interest Income Ann.	0.9%	10.6%	62.1	69.6	71.6	88.2	67.7	73.2	42	61.6	147.4	43.3	44.4	106.6
INT_A Interest Ann.	2.2%	-1.3%	383	384.4	407	424.6	360.1	353.6	410	491.1	448.5	397.2	430	464.7
EBITDA_A EBITDA Ann.	0.6%	-3.3%	3,379.3	3,290.5	2,927.9	2,982.2	3,231.9	3,437.7	3,891.3	3,862.7	3,762.6	3,097.9	3,085.9	2,743.9
ReconciledCostOfRevenue_A Reconciled Cost Of Rev. Ann.	1.2%	3.4%	14,307.1	14,598.7	14,579.3	14,528.6	14,087.8	12,541.7	12,321.6	12,080.7	11,392.1	11,779.9	11,534.8	10,433
ReconciledDepreciation_A Reconciled Depr. Ann.	-6.5%	-3.4%	1,556.9	1,500.4	1,742.3	1,752	1,838.4	1,623.7	1,785.9	1,593.2	724.9	735.5	737.8	656.1
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	10%	-3.7%	1,187.3	1,191.3	740.9	732.5	894.3	1,219	1,435.8	1,438.5	2,225.7	1,554.5	1,472.7	1,201.1
NormalizedEBITDA_A Normalized EBITDA Ann.	1.5%	-2.7%	3,670.9	3,578.2	3,416.1	3,438.6	3,417.8	3,549.1	4,101.5	3,895.6	3,101.1	3,141.2	3,290	2,890.9

*All financials are in EUR Million and price data in USD

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

1.5%

2Y CAGR

0.4%

3Y CAGR

0.4%

5Y CAGR

1.9%

7Y CAGR

2.5%

10Y CAGR

2.5%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

81.9%

2Y CAGR

40%

3Y CAGR

13.3%

5Y CAGR

-3.4%

7Y CAGR

-9.6%

10Y CAGR

0.4%

Net Profit Annual growth is higher than historical averages.

Operating Exp. Ann.

1Y CHG

-2.7%

2Y CAGR

-3.6%

3Y CAGR

-7.3%

5Y CAGR

-0.9%

7Y CAGR

0.9%

10Y CAGR

1.4%

Operating Expenses Annual Cr is falling faster than historical averages.

Fresenius Medical Care AG & Co. KGaA (ADR) balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Total Shareholders Fund Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Total Shareholders Fund is $13,310 Million which is growth of -8.7% YoY.
NEGATIVE
Total Assets Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Total Assets is $31,002 Million which is growth of -7.6% YoY.

Fresenius Medical Care AG & Co. KGaA - ADR, Balance Sheet, standalone, All financials are in EUR Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
TA_A Total Assets Ann. ⌄	-4.6%	-0.4%	31,002.3	33,566.6	33,929.8	35,754.1	34,366.6	31,689	32,934.7	26,242.3	24,025.1	25,609.9	23,354.5
CA_A Total Current Assets Ann.	-1.3%	1.7%	7,898.4	7,922.7	8,701.4	8,203.5	7,967.2	7,275.3	7,165.2	7,846.9	6,374.3	6,954.4	6,388.5
CashEquivalentsShortTermInvestments_A Cash Equivalents and Short Term Investments Ann.	8.1%	7.9%	1,821.3	1,446.6	1,539.8	1,443.8	1,618	1,243.2	1,141.1	2,245.2	981.6	961.8	751.4
Receivables_A Change In Account Receivables Ann.	-3.2%	0.2%	3,657.3	3,920.9	4,060.6	4,031.6	3,906.7	3,619	3,969.3	3,765.6	3,696.5	4,148.5	3,801.4
Inventories_A Inventories Ann.	-2.3%	2.5%	2,140.8	2,067.9	2,179.2	2,296.2	2,038	1,895.3	1,663.3	1,466.8	1,290.8	1,340.5	1,226.3
OtherCurrentAssets_A Other Current Assets Ann.	-15.5%	-14.2%	211.8	217.7	332.6	351.1	342.9	455.7	320.7	260.6	305.3	227.9	214.2
TotalNonCurrentAssets_A Total Non Current Assets Ann.	-5.7%	-1.1%	23,103.9	25,643.8	25,228.4	27,550.7	26,399.3	24,413.7	25,769.6	18,395.4	17,650.8	18,655.5	16,966
NetPPE_A Net PPE Ann.	-8%	-4.5%	6,499.8	7,258.6	7,454	8,339.8	8,551.5	8,186.8	8,515.4	3,836	3,491.8	3,587.7	3,133.2
InvestmentsAndAdvances_A Investments & Advances Ann.	19.6%	11.7%	1,323.5	1,416.7	1,254.5	773.7	786.9	761.1	696.9	649.8	647	645.9	589.7
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-35.5%	-22.4%	218.2	198.3	223.6	814.6	924.6	775	752.5	673	409.9	428.9	-
TotalLiabilitiesNetMinorityInterest_A Total Liabilities Net Minority Interest Ann. ⌄	-6.3%	-2.9%	16,719.5	17,798.1	19,103.3	20,304.9	20,387.5	19,357.7	19,707.5	13,340.3	13,196.9	14,716	13,754.2
CL_A Total Current Liabilities Ann.	-1.2%	0.3%	6,245.1	5,660.1	6,111.6	6,467.3	7,257.6	6,159.6	7,007.2	6,268.3	5,299.9	4,789.7	3,828.6
PayablesAndAccruedExpenses_A Payables & Accrued Exp.s Ann.	-3.3%	0.7%	1,378	1,520.1	1,478.9	1,524.8	1,402.2	1,332.1	937	863.3	1,513.6	2,645.8	2,212.1
CurrentDebtCapLeaseObligation_A Current Debt Cap Lease Obligation Ann.	2.6%	5.3%	2,197.3	1,218.3	1,561.6	2,036.9	2,585.4	1,696.8	3,257.8	2,500.7	1,652.8	1,301.8	725
CurrentDeferredLiabilities_Q Current Deferred Liabilities	2.7%	-28.4%	114.4	82.2	85.8	105.7	518	606.3	-	-	275.1	-	33.3
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-5.8%	-0.4%	1,440.3	1,664.9	1,847.3	1,721.7	1,659.8	1,467.9	-	-	153.6	842.1	858.3
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann.	-8.9%	-4.5%	10,474.4	12,138	12,991.7	13,837.6	13,129.9	13,198.1	12,700.3	7,072	7,897.1	9,926.4	9,925.6
LongTermDebtAndCapitalLeaseObligation_Q LT Debt & Capital Lease Obligation	-8.4%	-4.2%	8,598.3	9,760.6	10,488.9	11,175.7	10,734.8	10,683.2	10,524.6	5,045.5	5,794.9	6,848.5	7,183.3
TradeandOtherPayablesNonCurrent_A Trade & Other Payables Non Current Ann.	58.5%	6.6%	108.7	77	39.8	27.3	36.5	78.9	78	97.3	128.4	118.5	148.6
TotalDeferredCreditsAndOtherNonCurrentLiabilities_A Total Deferred Credits & Other Non Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	-1.6%	3.5%	13,309.8	14,576.6	13,620.3	13,989.5	12,698.8	11,215.1	11,957.9	11,758.4	9,820.1	10,277.4	9,043.4
EQCAP_A Equity Share Capital Ann.	-1.6%	3.5%	13,309.8	14,576.6	13,620.3	13,989.5	12,698.8	11,215.1	11,957.9	11,758.4	9,820.1	10,277.4	9,043.4
CapitalStock_A Capital Stock Ann.	0%	0%	293.4	293.4	293.4	293.4	293	292.9	304.4	307.9	308.1	360.9	354.1
RetainedEarnings_A Retained Earnings Ann.	4.5%	3.5%	12,207.9	11,266.3	10,921.7	10,711.7	10,826.1	10,254.9	9,454.9	8,831.9	7,137.3	8,402.6	7,199.3
GainsLossesNotAffectingRetainedEarnings_A Gains Losses Not Affecting Retained Earnings Ann.	-	-	-1,684.8	-328.6	-975.2	-388.5	-1,311.6	-2,205.3	-1,038.6	-1,203.8	-1,485.6	-1,254.2	-1,222.3
TotalCapitalization_A Total Capitalization Ann.	-3.5%	1.1%	19,001.7	20,837.4	20,580.1	21,160.2	19,345.7	18,015.2	18,416.2	16,803.9	15,615	17,125.8	16,226.6
TangibleAssets_A Tangible Assets Ann.	-	-	-1,516.1	-1,964.2	-2,392.1	-3,320.4	-3,122.2	-3,124.7	-3,485.7	-1,132.5	-2,966.9	-3,522.8	-3,636.8
WC_A Working Capital Ann.	-1.6%	8.2%	1,653.3	2,262.7	2,589.8	1,736.1	709.6	1,115.7	157.9	1,578.6	1,074.4	2,164.7	2,559.9
InvestedCapital_A Invested Capital Ann.	-2.9%	1.5%	20,614.7	21,414.8	21,524.7	22,523.3	21,269.6	19,102.8	21,035.3	19,304.6	17,267.8	18,427.6	16,951.6
TangibleBookValue_A Tangible Book Value Ann.	-	-	-1,516.1	-1,964.2	-2,392.1	-3,320.4	-3,122.2	-3,124.7	-3,485.7	-1,132.5	-2,966.9	-3,522.8	-3,636.8
Borrowings_A Borrowings Ann.	-6.5%	-2.7%	10,795.6	10,978.9	12,050.4	13,212.6	13,320.2	12,380	13,782.5	7,546.2	7,447.7	8,150.2	7,908.3
NetDebt_A Net Debt Ann.	-7.6%	-3.4%	5,722.4	5,687.3	6,501	7,260	7,089.1	6,806.2	8,069.7	5,400.6	6,469.6	7,439.7	7,405.6
ShareIssued_A Share Issued Ann.	0%	0%	293.4	293.4	293.4	293.4	293	292.9	304.4	307.9	308.1	307.2	312.9
SHARE_Q Number Of Shares End	-0.9%	-0.5%	571.7	586.8	586.8	586.8	586	585.7	598.5	613.7	613.8	612.4	610.3

*All financials are in EUR Million and price data in USD

Add metric to table

Search...

Total Assets Ann.

1Y CHG

-7.6%

2Y CAGR

-4.4%

3Y CAGR

-4.6%

5Y CAGR

-0.4%

7Y CAGR

2.4%

10Y CAGR

2.9%

Total Assets Annual is falling faster than historical averages.

Total Current Liabilities Ann.

1Y CHG

10.3%

2Y CAGR

1.1%

3Y CAGR

-1.2%

5Y CAGR

0.3%

7Y CAGR

-0.1%

10Y CAGR

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

-8.7%

2Y CAGR

-1.1%

3Y CAGR

-1.6%

5Y CAGR

3.5%

7Y CAGR

1.8%

10Y CAGR

3.9%

Total ShareHolders Funds Annual is falling faster than historical averages.

Fresenius Medical Care AG & Co. KGaA (ADR) ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Fresenius Medical Care AG & Co. KGaA (ADR) Book Value Per Share is $27 which is growth of 3.5% YoY.
NEUTRAL
ROE Fresenius Medical Care AG & Co. KGaA (ADR) ROE is 0% which is growth of 0% YoY.

Fresenius Medical Care AG & Co. KGaA - ADR, Ratios, standalone, All financials are in EUR Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
ROA_A RoA Ann. %	-	-	-	1.59%	1.43%	1.92%	2.93%	3.60%	4.05%	7.89%	5.16%	4.83%	4.25%
ROE_A ROE Ann. %	-	-	-	3.82%	3.61%	5.05%	8.11%	10.05%	10.12%	18.37%	12.74%	12.24%	11.20%
ROIC_Q ROIC %	-	-	-	0.5	1	0.7	1.1	1	1.6	2.5	2.6	2.8	2.2
OPMPCT_A OPM Ann. %	11.6%	-5.3%	9.31%	7.59%	7.59%	6.69%	9.99%	12.20%	12.40%	13.03%	12.91%	14.36%	13.71%
NBTO_A Inventory Turnover Ratio Ann.	-	-	-	6.9	6.5	6.5	6.4	6.9	7.7	8.3	9	9	9.7
ASETTO_A Asset Turnover Ann. %	-	-	-	0.6	0.6	0.6	0.5	0.6	0.6	0.7	0.7	0.7	0.7
WCTO_A Working Capital Turnover Ann.	2%	-5.7%	11.9	8.6	7.5	11.2	24.8	16	110.7	10.5	16.6	7.9	6
QuickRatio_A Quick Ratio Ann.	-	-	-	1	0.9	0.9	0.8	0.8	0.7	1	0.9	1.1	1.2
CRATIO_A Current Ratio Ann.	-	-	-	1.4	1.4	1.3	1.1	1.2	1	1.3	1.2	1.5	1.7
IC_A Interest Coverage Ratio Ann.	-	-	-	3.6	3.4	4.4	5.5	5.7	4.8	7.1	6.1	5.9	4.8
LTDE_A LT Debt To Equity Ann.	-	-	-	0.7	0.8	0.8	0.9	1	0.9	0.4	0.6	0.7	0.8

*All financials are in EUR Million and price data in USD

Add metric to table

Search...

Fresenius Medical Care AG & Co. KGaA (ADR) cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Cash From Operating Activity is $2,681 Million which is growth of 12.4% YoY.
POSITIVE
Net Cash Flow Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Net Cash Flow is $555 Million which is growth of 307.1% YoY.

Fresenius Medical Care AG & Co. KGaA - ADR, Cash Flow, standalone, All financials are in EUR Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
CFO_A Cash from Operating Act. Ann. ⌄	7.3%	-8.7%	2,681	2,386.1	2,628.8	2,167.4	2,489.5	4,233.2	2,567	2,061.9	2,191.8	2,034.7	1,792.8
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	10%	-3.7%	1,191.3	740.9	732.5	894.3	1,219	1,435.8	1,438.5	2,225.7	1,554.5	1,472.7	1,201.1
DepreciationAmortizationDepletion_A Depreciation Amortization Depletion Ann.	-6.5%	-3.4%	1,500.4	1,742.3	1,752	1,838.4	1,623.7	1,785.9	1,593.2	724.9	735.5	737.8	656.1
DepreciationAndAmortization_A Depreciation And Amortization Ann.	-6.5%	-3.4%	1,500.4	1,742.3	1,752	1,838.4	1,623.7	1,785.9	1,593.2	724.9	735.5	737.8	656.1
DeferredTax_A Deferred Tax Ann.	-	-	-27.2	-72.7	-122.2	-41.5	67.3	111.1	64.3	89.2	-203.1	-5.4	-41.6
DeferredIncomeTax_A Deferred Income Tax Ann.	-	-	-27.2	-72.7	-122.2	-41.5	67.3	111.1	64.3	89.2	-203.1	-5.4	-41.6
EmployeesStockOptions_A ESOPs Ann.	-	-	-	-	-	-			2	10.7	46.8	28.7	11.3
OtherNonCashItems_A Other Non Cash Items Ann.	2.5%	-3.1%	314.8	335.5	336.4	292.5	280.4	368	429.4	-	-	-	-
ChangeInWorkingCapital_A Change In Working Capital Ann.	-	-35.5%	138.2	444.3	561.3	-128.1	-97.8	1,235.5	-12.5	460.5	1,209.9	-141.2	-15.7
ChangeInReceivables_A Change In Receivables Ann.	-	-	-69.1	-73.5	-151.8	-46.7	-163.2	71.7	-64.1	-170.5	-86.3	-305.9	-303
ChangeInInventory_A Change In Inventory Ann.	-	-	-248.7	107.9	-13.1	-204.3	-48.5	-355.8	-117.5	-157.1	-62.7	-63.4	-275.3
ChangePayablesAccruedExpense_A Change Payables Accrued Expense Ann.	-	-31.9%	249.1	637.9	580.6	-31.1	-50.2	1,698.1	215.3	883.4	1,173	177	518.7
ChangeInOtherCurrentAssets_A Change In Other Current Assets Ann.	10.3%	-	206.9	-228	145.7	154	164.2	-178.5	-46.1	-95.3	185.8	-	-
ChangeInOtherCurrentLiabilities_A Change In Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherWorkingCapital_A Change In Other Working Capital Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
CFI_A Cash from Investing Act. Ann. ⌄	-	-	-722.5	-84.9	-544.2	-734.7	-1,196.2	-1,334.9	-3,286	-245	-991.5	-1,311.5	-915.3
NetPPEPurchaseAndSale_A Net PPE Purchase & Sale Ann.	-	-	-898.7	-685.3	-668.5	-687.8	-829.9	-1,036.4	-1,113.3	-1,002.8	-841.2	-962.6	-855.7
PurchaseOfPPE_A Purchase Of PPE Ann.	-	-	-915.4	-699.4	-684.6	-724	-854.4	-1,052	-1,124.8	-1,057.3	-944.5	-979.4	-871.6
NetBusinessPurchaseAndSale_A Net Business Purchase & Sale Ann.	464.8%	-	180.2	606.7	137	1	-381.7	-244.4	-2,172.7	757.7	-150.3	-349	-59.6
PurchaseOfBusiness_A Purchase Of Business Ann.	-	-	-22	-23.1	-35.2	-59.1	-434.2	-259	-2,232.7	-925.3	-565.7	-549.2	-289.8
PurchaseOfInvestment_A Purchase Of Investment Ann.	-	-	-87.5	-81.5	-102.4	-105.6	-129.1	-96.4	-	-	-	-	-
SaleOfInvestment_A Sale Of Investment Ann.	13.1%	14.6%	83.5	75.1	89.6	57.7	144.5	42.2	-	-	-	-	-
NetOtherInvestingChanges_A Net Other Investing Changes Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
CFA_A Cash from Financing Act. Ann. ⌄	-	-	-1,403.2	-2,569.3	-1,858.5	-1,617.4	-1,024.4	-2,664	-466.6	-681.7	-798.6	-556	-921.6
NetIssuancePaymentsOfDebt_A Net Issuance Payments Of Debt Ann.	-	-	149.6	-1,905.2	-1,259.2	-1,118	-358.9	-1,266	318.6	160.9	-308.3	-223	-302.4
NetLongTermDebtIssuance_A Net Long Term Debt Issuance Ann.	-	-	133.9	-1,449.5	-1,010.2	-532.9	-1,535.9	-169.1	556.1	-463.8	-517	-694.7	-291.6
NetShortTermDebtIssuance_A Net ST Debt Issuance Ann.	-	-	15.7	-455.7	-249	-585.2	1,177	-1,096.9	-237.5	624.7	208.7	471.7	-10.8
NetCommonStockIssuance_A Net Common Stock Issuance Ann.	-	-	-585.3	-	-			-366	-599.8	-37.2	-57.9	-	-
CommonStockIssuance_A Common Stock Issuance Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
CommonStockPayments_A Common Stock Payments Ann.	-	-	-585.3	-	-			-366	-599.8	-37.2	-57.9	-	-
dividend_1Y_actual Dividend 1year	4.6%	2.7%	0.8	0.6		0.7	0.8	0.7	0.7	0.6	0.5	0.5	0.4
DividendPerShare_A Dividend Per Share Ann.	0%	3.1%	0.7	0.6	0.6	0.7	0.7	0.6	0.6	0.5	0.5	0.4	0.4
NetOtherFinancingCharges_A Net Other Financing Charges Ann.	-	-	-545	-315	-270.8	-124	-279.5	-693.5	153.4	-528	-186	-116.2	-464.5
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	7.9%	8.1%	1,599.1	1,185.3	1,427.2	1,273.8	1,481.7	1,081.5	1,007.7	2,145.6	978.1	710.5	502.6
NetIncDecInCashAndCashEquivalents_A Net Increase In Cash Plus Cash Eqv.s Ann.	-	18.8%	555.3	-268.1	226	-184.7	268.9	234.2	-1,185.7	1,135.1	401.6	167.2	-44.1
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-7.2%	3.3%	1,185.3	1,427.2	1,273.8	1,481.7	1,081.5	1,007.7	2,145.6	978.1	708.9	522.5	579.8
IncomeTaxPaidSupplementalData_A Income Tax Paid Supplemental Data Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
InterestPaidSupplementalData_A Interest Paid Supplemental Data Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
CapitalExpenditure_A Capex Ann.	-	-	-915.4	-699.4	-684.6	-724	-854.4	-1,052	-1,124.8	-1,057.3	-944.5	-979.4	-871.6
IssuanceOfCapitalStock_A Issuance Of Capital Stock Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
IssuanceOfDebt_A Issuance Of Debt Ann.	1.4%	-9.4%	1,779	146.3	483.2	1,704	3,048.3	2,915.7	4,479.4	1,480.7	1,148.4	980.5	322.3
RepaymentOfDebt_A Repayment Of Debt Ann.	-	-	-1,629.4	-2,051.5	-1,742.4	-2,822	-3,407.2	-4,181.7	-4,160.9	-1,319.7	-1,456.7	-1,203.4	-624.7
RepurchaseOfCapitalStock_A Repurchase Of Capital Stock Ann.	-	-	-585.3	-	-			-366	-599.8	-37.2	-57.9	-	-
FreeCashFlow_A Free Cash Flow Ann.	6.9%	-11.1%	1,765.6	1,686.8	1,944.2	1,443.4	1,635.1	3,181.2	1,442.2	1,004.6	1,247.4	1,003.4	907.8

*All financials are in EUR Million and price data in USD

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

12.4%

2Y CAGR

3Y CAGR

7.3%

5Y CAGR

-8.7%

7Y CAGR

3.8%

10Y CAGR

4.1%

Cash from Operating Activity Annual growth is higher than historical averages.

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow

Fresenius Medical Care AG & Co. KGaA (ADR) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Fresenius Medical Care AG & Co. KGaA (ADR) - Forecaster

Forecaster Analyst Estimates for Fresenius Medical Care AG & Co. KGaA (ADR) share price target, revenues, EPS, net income and more

Fresenius Medical Care AG & Co. KGaA (ADR) - Earnings Report - Quarterly Results

Fresenius Medical Care AG & Co. KGaA (ADR) quarterly results: revenue, profit, and P&L – 13 quarter history

Quarterly Revenue Fresenius Medical Care AG & Co. KGaA (ADR) Jun-2026 Quarterly Revenue is $4,861 Million which is growth of 1.4% YoY.

Quarterly Net Profit Fresenius Medical Care AG & Co. KGaA (ADR) Jun-2026 Quarterly Net Profit is $218 Million which is growth of -3.1% YoY.

Fresenius Medical Care AG & Co. KGaA (ADR) - Competitors/Peers

Fresenius Medical Care AG & Co. KGaA (ADR) competitor comparison and performance snapshot within industry

Fresenius Medical Care AG & Co. KGaA (ADR) - Earnings Report - Annual Results

Fresenius Medical Care AG & Co. KGaA (ADR) annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Annual Revenue Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Annual Revenue is $19,628 Million which is growth of 1.5% YoY.

Annual Net Profit Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Annual Net Profit is $978 Million which is growth of 81.9% YoY.

Fresenius Medical Care AG & Co. KGaA (ADR) - Balance Sheet

Fresenius Medical Care AG & Co. KGaA (ADR) balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Total Shareholders Fund is $13,310 Million which is growth of -8.7% YoY.

Total Assets Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Total Assets is $31,002 Million which is growth of -7.6% YoY.

Fresenius Medical Care AG & Co. KGaA (ADR) - Ratios

Fresenius Medical Care AG & Co. KGaA (ADR) ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Book Value Per Share Fresenius Medical Care AG & Co. KGaA (ADR) Book Value Per Share is $27 which is growth of 3.5% YoY.

ROE Fresenius Medical Care AG & Co. KGaA (ADR) ROE is 0% which is growth of 0% YoY.

Fresenius Medical Care AG & Co. KGaA (ADR) - Cash Flow

Fresenius Medical Care AG & Co. KGaA (ADR) cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Cash From Operating Activity Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Cash From Operating Activity is $2,681 Million which is growth of 12.4% YoY.

Net Cash Flow Fresenius Medical Care AG & Co. KGaA (ADR) Dec-2025 Net Cash Flow is $555 Million which is growth of 307.1% YoY.